,title,source,link,date
11,"Dopamine Agonists Market Global Report | GSK, Roche, Merck ...",Argyle Report,news.google.com/articles/CBMiaGh0dHBzOi8vd3d3LmFyZ3lsZXJlcG9ydC5jb20vYnVzaW5lc3MvZG9wYW1pbmUtYWdvbmlzdHMtbWFya2V0LWdsb2JhbC1yZXBvcnQtZ3NrLXJvY2hlLW1lcmNrLXVjYi8yNDQ1NTMv0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-04
16,Prostate Cancer PARP Inhibitor Drugs Market Global Report | Merck ...,Argyle Report,news.google.com/articles/CBMif2h0dHBzOi8vd3d3LmFyZ3lsZXJlcG9ydC5jb20vYnVzaW5lc3MvcHJvc3RhdGUtY2FuY2VyLXBhcnAtaW5oaWJpdG9yLWRydWdzLW1hcmtldC1nbG9iYWwtcmVwb3J0LW1lcmNrLWNvLWluYy1nc2stcGZpemVyLzI0MDA0MC_SAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-03
9,Focal Segmental Glomerulosclerosis Drug Market Report Analysis ...,Argyle Report,news.google.com/articles/CBMivwFodHRwczovL3d3dy5hcmd5bGVyZXBvcnQuY29tL2J1c2luZXNzL2ZvY2FsLXNlZ21lbnRhbC1nbG9tZXJ1bG9zY2xlcm9zaXMtZHJ1Zy1tYXJrZXQtcmVwb3J0LWFuYWx5c2lzLXJlc2VhcmNoLXN0dWR5LWRpbWVyaXgtYmlvc2NpZW5jZS1wdHktbHRkLWdsYXhvc21pdGhrbGluZS1wbGMtcmV0cm9waGluLWluYy10YWtlZGEvMjQxMjY4L9IBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-03
17,Monoclonal Antibody Treatment Market Growth Report | Bayer ...,Argyle Report,news.google.com/articles/CBMigwFodHRwczovL3d3dy5hcmd5bGVyZXBvcnQuY29tL2J1c2luZXNzL21vbm9jbG9uYWwtYW50aWJvZHktdHJlYXRtZW50LW1hcmtldC1ncm93dGgtcmVwb3J0LWJheWVyLXNhbm9maS1tZXJjay1nbGF4b3NtaXRoa2xpbmUvMTk4NTg4L9IBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-03
39,Generic Active Pharmaceutical Ingredients Rapidly Growing Market ...,Argyle Report,news.google.com/articles/CBMitQFodHRwczovL3d3dy5hcmd5bGVyZXBvcnQuY29tL2J1c2luZXNzL2dlbmVyaWMtYWN0aXZlLXBoYXJtYWNldXRpY2FsLWluZ3JlZGllbnRzLXJhcGlkbHktZ3Jvd2luZy1tYXJrZXQtZ2xvYmFsbHktaW5jLXUtcy1ub3ZhcnRpcy1pbnRlcm5hdGlvbmFsLWFnLXNhbm9maS1ib2VocmluZ2VyLWluZ2VsaGVpbS8xOTY0MzQv0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-03
13,Biologic Therapeutic Drug Market Analysis to 2029 | Concord ...,Argyle Report,news.google.com/articles/CBMiogFodHRwczovL3d3dy5hcmd5bGVyZXBvcnQuY29tL2J1c2luZXNzL2Jpb2xvZ2ljLXRoZXJhcGV1dGljLWRydWctbWFya2V0LWFuYWx5c2lzLXRvLTIwMjktY29uY29yZC1iaW90ZWNoLWdsYXhvc21pdGhrbGluZS1wbGMtaC1sdW5kYmVjay1hLXMtbm92YXJ0aXMtZ2xvYmFsLzE5NjMxNS_SAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-03
21,Nasal Vaccines Market Overall Study Report 2023-2030 ...,Kalkine Media,news.google.com/articles/CBMiiAFodHRwczovL2thbGtpbmVtZWRpYS5jb20vbmV3cy93b3JsZC1uZXdzL25hc2FsLXZhY2NpbmVzLW1hcmtldC1vdmVyYWxsLXN0dWR5LXJlcG9ydC0yMDIzLTIwMzAtYXN0cmF6ZW5lY2EtZ2xheG9zbWl0aGtsaW5lLXBsYy1wZml6ZXItaW5j0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-03
50,Prochlorperazine Maleate Market Growth and Restrain Factors Analysis 2023-2031,openPR,news.google.com/articles/CBMiX2h0dHBzOi8vd3d3Lm9wZW5wci5jb20vbmV3cy8zMjc1NjgyL3Byb2NobG9ycGVyYXppbmUtbWFsZWF0ZS1tYXJrZXQtZ3Jvd3RoLWFuZC1yZXN0cmFpbi1mYWN0b3Jz0gFeaHR0cHM6Ly93d3cub3BlbnByLmNvbS9hbXAvMzI3NTY4Mi9wcm9jaGxvcnBlcmF6aW5lLW1hbGVhdGUtbWFya2V0LWdyb3d0aC1hbmQtcmVzdHJhaW4tZmFjdG9ycw?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-03
8,GSK Exit: Shareholders to receive N17.42 per share as it ends Nigerian business,Nairametrics,news.google.com/articles/CBMiamh0dHBzOi8vbmFpcmFtZXRyaWNzLmNvbS8yMDIzLzExLzAzL2dzay10by1wYXktc2hhcmVob2xkZXJzLW4xNy00Mi1wZXItc2hhcmUtYXMtaXQtZW5kcy1uaWdlcmlhbi1idXNpbmVzcy_SAXBodHRwczovL25haXJhbWV0cmljcy5jb20vMjAyMy8xMS8wMy9nc2stdG8tcGF5LXNoYXJlaG9sZGVycy1uMTctNDItcGVyLXNoYXJlLWFzLWl0LWVuZHMtbmlnZXJpYW4tYnVzaW5lc3MvP2FtcD0x?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-03
26,"SPARC announces retirement of Dr Chitturi Trinadha Rao â€“ Senior Vice President, Drug Discovery",Medical Dialogues,news.google.com/articles/CBMikwFodHRwczovL21lZGljYWxkaWFsb2d1ZXMuaW4vbmV3cy9pbmR1c3RyeS9waGFybWEvc3BhcmMtYW5ub3VuY2VzLXJldGlyZW1lbnQtb2YtZHItY2hpdHR1cmktdHJpbmFkaGEtcmFvLXNlbmlvci12aWNlLXByZXNpZGVudC1kcnVnLWRpc2NvdmVyeS0xMTk3MDPSAZcBaHR0cHM6Ly9tZWRpY2FsZGlhbG9ndWVzLmluL2FtcC9uZXdzL2luZHVzdHJ5L3BoYXJtYS9zcGFyYy1hbm5vdW5jZXMtcmV0aXJlbWVudC1vZi1kci1jaGl0dHVyaS10cmluYWRoYS1yYW8tc2VuaW9yLXZpY2UtcHJlc2lkZW50LWRydWctZGlzY292ZXJ5LTExOTcwMw?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-03
